Get Your Free Guide to Understanding MS Clinical Trials

What Multiple Sclerosis Clinical Trials Are and How They Work

Multiple sclerosis (MS) clinical trials are research studies that test new treatments, medications, devices, or approaches to managing MS. These trials involve volunteers who participate in structured research to help scientists understand whether new treatments work better than current options, how safe they are, and what side effects they might cause.

Clinical trials follow a specific pathway. First, researchers develop a treatment idea based on laboratory research and animal testing. Before any humans participate, the treatment must go through rigorous review by ethics committees. Once approved, the trial moves through different phases. Phase 1 trials involve a small group of people—usually 20 to 100—and focus mainly on safety and proper dosage. Phase 2 trials expand to 100 to 300 participants and begin measuring whether the treatment actually works for MS. Phase 3 trials involve 1,000 to 3,000 people and compare the new treatment to existing treatments or placebos. Phase 4 trials happen after a treatment is approved and released to the public, monitoring long-term effects.

According to the National Institutes of Health, there are typically between 2,000 and 3,000 clinical trials happening in the United States at any given time. For MS specifically, researchers are constantly testing new approaches because the disease affects people differently and no single treatment works equally well for everyone.

Practical takeaway: Understanding that clinical trials exist in phases helps you realize that some trials test brand-new ideas still being refined, while others test treatments that are nearly ready for market release. Knowing which phase a trial is in can help you understand what level of risk and what types of results to expect.

Types of MS Clinical Trials and What Researchers Are Currently Testing

MS clinical trials test many different approaches because researchers are working to combat multiple aspects of the disease. The main categories of current research include new medications, different delivery methods for existing drugs, combination therapies using multiple treatments together, rehabilitation approaches, and lifestyle interventions.

Many current trials focus on disease-modifying therapies (DMTs)—medications that slow the progression of MS. Researchers are testing newer versions of these drugs that may work better or cause fewer side effects than existing options. Some trials explore whether certain DMTs work better for specific types of MS, like relapsing-remitting MS versus progressive forms.

Other active research areas include symptom management. Trials are testing treatments for fatigue, which affects up to 80% of people with MS. Additional trials focus on cognitive problems, muscle weakness, vision problems, and pain. Some researchers study whether certain lifestyle changes—like specific exercise programs, dietary approaches, or sleep interventions—can improve symptoms or slow disease progression.

Emerging areas of MS research include regenerative medicine and stem cell therapies, which aim to repair damage the disease has already caused. Other trials test immunotherapy approaches designed to retrain the immune system to stop attacking nerve tissue. Some research explores whether treating MS differs based on a person's genetic makeup or other individual factors.

As of 2024, the FDA has approved over 20 different MS medications, yet researchers continue developing new options because existing treatments don't work equally well for everyone, some people experience intolerable side effects, and progressive forms of MS remain particularly difficult to treat.

Practical takeaway: Before considering participation in any trial, review what specific aspect of MS or what specific treatment the trial is testing. This helps you understand whether the research matches your personal situation and what kind of results the researchers are actually measuring.

The Benefits and Risks of Participating in Clinical Trials

People who participate in MS clinical trials may receive several potential benefits. The most direct benefit is receiving close medical monitoring and frequent check-ins with MS specialists. Participants often undergo more comprehensive testing—including MRI scans, blood work, and neurological exams—than they might receive in routine care. This monitoring can sometimes catch health changes early.

Some trial participants receive access to new treatments before they become available to the general public. If a new treatment proves effective in early trials, participants may benefit from this cutting-edge approach. Additionally, participants contribute to scientific knowledge that ultimately helps future MS patients by providing data that informs treatment development.

Many trials offer free medications and free medical visits related to the trial, which can reduce out-of-pocket costs. Some trials also provide compensation for participants' time and travel expenses, though the amount varies widely.

However, clinical trials also carry risks. New treatments may cause unexpected side effects that researchers didn't anticipate. Some participants receive a placebo—an inactive substance—instead of the treatment being tested, meaning they might not receive any active medication during the trial period. The time commitment can be substantial, with some trials requiring weekly visits or more.

Participating in a trial may also involve additional risk if the new treatment is less effective than existing options or if it causes problems. Researchers monitor for serious adverse events and can stop trials if safety concerns emerge, but individual participants could still experience harm.

Practical takeaway: Before entering any trial, carefully review the informed consent document, which explains specific benefits and risks. Ask the research team directly about what happens if you experience side effects, whether you can leave the trial, what happens to your medical care afterward, and whether compensation is provided for injuries caused by the trial treatment.

How to Find MS Clinical Trials and Evaluate Your Options

Several resources exist for locating MS clinical trials currently recruiting participants. The primary resource is ClinicalTrials.gov, a searchable database maintained by the National Library of Medicine that lists virtually all clinical trials in the United States and many international trials. You can search by location, trial phase, treatment type, or MS category.

The National MS Society maintains a clinical trials information service and website where you can search MS-specific trials. Individual pharmaceutical companies often list trials on their websites when they're testing new MS medications. Your MS specialist may also know about trials recruiting at their medical center or nearby institutions.

When you find a trial that interests you, gather key information before contacting the research team. Write down the trial's official name, the sponsoring organization, the specific treatment being tested, the trial location, the expected duration, and the contact information. Review the listed inclusion and exclusion criteria, which describe who can and cannot participate.

Evaluate whether the trial's requirements fit your life situation. Consider whether you can commit to the required visit schedule. If the trial requires weekly in-person visits but you live two hours away, travel might be impractical. Review what specific measurements or tests the trial involves and whether any concern you.

Look at what phase the trial is in. Phase 1 trials represent earlier research stages with less known about safety. Phase 3 and 4 trials involve treatments further along in development. Check how many people are involved and how long the trial lasts. Larger, longer trials often provide more reliable information.

Practical takeaway: Create a comparison list if you're considering multiple trials. Note the treatment being tested, location, visit frequency, duration, what tests are involved, and whether compensation is offered. This organized approach helps you make a clear decision rather than feeling overwhelmed by information.

Understanding the Informed Consent Process and Your Rights

Before you participate in any clinical trial, researchers must obtain your informed consent. This is a legal and ethical requirement, not optional. Informed consent means you understand what the trial involves, what risks exist, what benefits might occur, and what your rights are—and you freely choose to participate.

The informed consent process begins with a detailed conversation with the research team. They should explain the trial's purpose in language you understand, not medical jargon. They must describe the procedures you'll undergo, how often you'll visit, how long you'll participate, and what the treatment is. They should explain known side effects and potential unknown risks. They must tell you about alternative treatments that exist outside the trial.

You receive a written informed consent document that summarizes all this information. You should receive a copy to keep. Don't feel rushed to sign. You have the right to take the document home, discuss it with your doctor or family, ask questions, and take time to decide. Any pressure to sign quickly is a red flag.

Important rights you have include the right to leave the trial at any time without penalty or loss of medical care. You have the right to ask questions at any point. You have the right to request a copy of your data. You have the right to refuse specific procedures within the trial. You have the right to contact an Institutional Review Board (IRB)—an independent ethics committee—if you believe your rights have been violated.